Denali Therapeutics Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Denali Therapeutics Inc. (DNLI) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$1.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-06
- Denali Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$1.29M.
- Denali Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$1.36M, a 8123.53% decline year-over-year.
- Denali Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was -$419.00K.
- Denali Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $162.00K, a 98.02% decline year-over-year.
- Denali Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was -$1.34M, a 197.17% decline from fiscal 2024.
- Denali Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $1.38M, a 81.71% decline from fiscal 2023.
- Denali Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $7.53M.
- Denali Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$4.39M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.29M 10-Q · filed 2026-08-06 | -$2.65M 10-Q · filed 2026-08-06 | -$3.07M derived: sum of 3 quarters · filed 2026-08-06 | -$2.91M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$1.36M 10-Q · filed 2026-05-07 | -$1.78M derived: sum of 2 quarters · filed 2026-05-07 | -$1.62M derived: sum of 3 quarters · filed 2026-05-07 | -$2.72M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$419.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$257.00K derived: sum of 2 quarters · filed 2026-02-26 | -$1.35M derived: sum of 3 quarters · filed 2026-08-06 | -$1.34M 10-K · filed 2026-02-26 |
| 2025-09-30 | $162.00K 10-Q · filed 2025-11-06 | -$936.00K derived: sum of 2 quarters · filed 2026-08-06 | -$919.00K 10-Q · filed 2025-11-06 | -$4.43M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.10M 10-Q · filed 2026-08-06 | -$1.08M 10-Q · filed 2026-08-06 | -$4.59M derived: sum of 3 quarters · filed 2026-08-06 | $3.60M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $17.00K 10-Q · filed 2026-05-07 | -$3.49M derived: sum of 2 quarters · filed 2026-05-07 | $4.70M derived: sum of 3 quarters · filed 2026-05-07 | $3.33M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$3.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.68M derived: sum of 2 quarters · filed 2026-02-26 | $3.32M derived: sum of 3 quarters · filed 2026-02-26 | $1.38M 10-K · filed 2026-02-26 |
| 2024-09-30 | $8.19M 10-Q · filed 2025-11-06 | $6.83M derived: sum of 2 quarters · filed 2025-11-06 | $4.89M 10-Q · filed 2025-11-06 | $6.18M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$1.36M 10-Q · filed 2025-08-11 | -$3.30M 10-Q · filed 2025-08-11 | -$2.01M derived: sum of 3 quarters · filed 2026-02-26 | -$1.22M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$1.94M 10-Q · filed 2025-05-06 | -$645.00K derived: sum of 2 quarters · filed 2026-02-26 | $145.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.22M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.08M derived: sum of 2 quarters · filed 2026-02-26 | $3.16M derived: sum of 3 quarters · filed 2026-02-26 | $7.53M 10-K · filed 2026-02-26 |
| 2023-09-30 | $790.00K 10-Q · filed 2024-11-06 | $1.87M derived: sum of 2 quarters · filed 2024-11-06 | $6.24M 10-Q · filed 2024-11-06 | $11.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.08M 10-Q · filed 2024-08-01 | $5.45M 10-Q · filed 2024-08-01 | $10.41M derived: sum of 3 quarters · filed 2025-02-27 | $10.83M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $4.37M 10-Q · filed 2024-05-07 | $9.34M derived: sum of 2 quarters · filed 2025-02-27 | $9.76M derived: sum of 3 quarters · filed 2025-02-27 | $6.73M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $4.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $5.39M derived: sum of 2 quarters · filed 2025-02-27 | $2.37M derived: sum of 3 quarters · filed 2025-02-27 | -$4.39M 10-K · filed 2025-02-27 |
| 2022-09-30 | $421.00K 10-Q · filed 2023-11-07 | -$2.60M derived: sum of 2 quarters · filed 2023-11-07 | -$9.35M 10-Q · filed 2023-11-07 | -$11.33M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$3.02M 10-Q · filed 2023-08-08 | -$9.78M 10-Q · filed 2023-08-08 | -$11.75M derived: sum of 3 quarters · filed 2024-02-28 | -$11.91M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$6.75M 10-Q · filed 2023-05-08 | -$8.73M derived: sum of 2 quarters · filed 2024-02-28 | -$8.88M derived: sum of 3 quarters · filed 2024-02-28 | -$9.02M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$2.13M derived: sum of 2 quarters · filed 2024-02-28 | -$2.27M derived: sum of 3 quarters · filed 2024-02-28 | -$2.25M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$153.00K 10-Q · filed 2022-11-03 | -$289.00K derived: sum of 2 quarters · filed 2022-11-03 | -$276.00K 10-Q · filed 2022-11-03 | -$532.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | -$136.00K 10-Q · filed 2022-08-08 | -$123.00K 10-Q · filed 2022-08-08 | -$379.00K derived: sum of 3 quarters · filed 2023-02-27 | -$919.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $13.00K 10-Q · filed 2022-05-05 | -$243.00K derived: sum of 2 quarters · filed 2023-02-27 | -$783.00K derived: sum of 3 quarters · filed 2023-02-27 | -$1.07M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | -$256.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$796.00K derived: sum of 2 quarters · filed 2023-02-27 | -$1.08M derived: sum of 3 quarters · filed 2023-02-27 | -$595.00K 10-K · filed 2023-02-27 |
| 2020-09-30 | -$540.00K 10-Q · filed 2021-11-04 | -$824.00K derived: sum of 2 quarters · filed 2021-11-04 | -$339.00K 10-Q · filed 2021-11-04 | -$551.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$284.00K 10-Q · filed 2021-08-04 | $201.00K 10-Q · filed 2021-08-04 | -$11.00K derived: sum of 3 quarters · filed 2022-02-28 | -$328.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $485.00K 10-Q · filed 2021-05-05 | $273.00K derived: sum of 2 quarters · filed 2022-02-28 | -$44.00K derived: sum of 3 quarters · filed 2022-02-28 | $503.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$529.00K derived: sum of 2 quarters · filed 2022-02-28 | $18.00K derived: sum of 3 quarters · filed 2022-02-28 | $999.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | -$317.00K 10-Q · filed 2020-11-05 | $230.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.21M 10-Q · filed 2020-11-05 | $1.98M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $547.00K 10-Q · filed 2020-08-07 | $1.53M 10-Q · filed 2020-08-07 | $2.29M derived: sum of 3 quarters · filed 2021-02-26 | $2.37M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $981.00K 10-Q · filed 2020-05-07 | $1.75M derived: sum of 2 quarters · filed 2021-02-26 | $1.82M derived: sum of 3 quarters · filed 2021-02-26 | $1.62M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $767.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $844.00K derived: sum of 2 quarters · filed 2021-02-26 | $638.00K derived: sum of 3 quarters · filed 2021-02-26 | -$281.00K 10-K · filed 2021-02-26 |
| 2018-09-30 | $77.00K 10-Q · filed 2019-11-06 | -$129.00K derived: sum of 2 quarters · filed 2019-11-06 | -$1.05M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | -$206.00K 10-Q · filed 2019-08-06 | -$1.13M 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | -$919.00K 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | $5.00K 10-K · filed 2020-02-27 | |||
| 2016-12-31 | -$373.00K 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |